CoChat

Integration of Alzheimer’s disease genetics and myeloid genomics reveals novel disease risk mechanisms: Functionalizing genetic variants in Alzheimer’s disease

Open access
Novikova, Gloriia, Marcora, Edoardo, Kapoor, Manav, TCW, Julia, Renton, Alan E., Efthymiou, Anastasia M., Abud, Edsel M., Bendl, Jaroslav M., Cheng, Haoxiang M., Fullard, John F., Roussos, Panos, Poon, Wayne W., Hao, Ke, Goate, Alison M. · 2020 · Alzheimer's & Dementia
Cited by 27

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Abstract

Background: Genome‐wide association studies (GWAS) have identified more than forty loci associated with Alzheimer’s disease (AD), but the causal variants, regulatory elements and genes remain largely unknown, impeding a mechanistic understanding of AD pathogenesis. Method: We used an integrative genomic approach to determine the epigenomic annotations enriched for AD risk variants and applied a summary‐data based Mendelian Randomization to link myeloid enhancer activity to target gene expression regulation and AD risk modification. Result: We show that AD risk variants are specifically enriched in active enhancers of monocytes, macrophages and microglia, nominate candidate AD risk enhancers and identify their target causal genes (including AP4E1, AP4M1, APBB3, BIN1, CD2AP, MS4A4A, MS4A6A, PILRA, RABEP1, SPI1, SPPL2A, TP53INP1, ZKSCAN1, and ZYX) in sixteen loci. Fine‐mapping of these enhancers nominates candidate functional variants that likely modify disease susceptibility by regulating causal gene expression specifically in myeloid cells. In the MS4A locus we identified a single candidate functional variant within an CTCF binding site, that is predicted to alter chromatin looping and MS4A gene expression. We used human induced pluripotent stem cells (hiPSC)‐derived microglia to provide experimental validation of this putative causal variant. Conclusion: Combined, these results strongly implicate dysfunction of myeloid cell endo‐lysosomal pathways involved in clearance of lipid rich debris in the etiology of AD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/alz.043897

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 25 references

Cited by

See all 27

Metadata

Authors
Novikova, G., Marcora, E., Kapoor, M., TCW, J., Renton, A. E., Efthymiou, A. M., Abud, E. M., Bendl, J. M., Cheng, H. M., Fullard, J. F., Roussos, P., Poon, W. W., Hao, K., & Goate, A. M.
Venue
Alzheimer's & Dementia
Publisher
Wiley
Published
2020-12
Volume
16
Issue
S3
ISSN
  • 1552-5260 (ISSN-L)
  • 1552-5279
OpenAlex
W3112157117
Cited by
27
References
25
FWCI
2.89
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Integration of Alzheimer’s disease genetics and myeloid genomics reveals novel disease risk mechanisms: Functionalizing genetic variants in Alzheimer’s disease. https://app.cochat.ai/papers/10.1002/alz.043897
The paper
Novikova, G., Marcora, E., Kapoor, M., TCW, J., Renton, A. E., Efthymiou, A. M., Abud, E. M., Bendl, J. M., Cheng, H. M., Fullard, J. F., Roussos, P., Poon, W. W., Hao, K., & Goate, A. M. (2020). Integration of Alzheimer’s disease genetics and myeloid genomics reveals novel disease risk mechanisms: Functionalizing genetic variants in Alzheimer’s disease. Alzheimer's & Dementia. https://doi.org/10.1002/alz.043897

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.